Apogee Therapeutics
APGE
139 hedge funds and large institutions have $3.29B invested in Apogee Therapeutics in 2024 Q3 according to their latest regulatory filings, with 25 funds opening new positions, 48 increasing their positions, 46 reducing their positions, and 25 closing their positions.
75% more funds holding in top 10
Funds holding in top 10: 4 → 7 (+3)
55% more capital invested
Capital invested by funds: $2.13B → $3.29B (+$1.16B)
4.24% more ownership
Funds ownership: 120.42% → 124.65% (+4.2%)
4% more repeat investments, than reductions
Existing positions increased: 48 | Existing positions reduced: 46
0% more funds holding
Funds holding: 139 → 139 (0)
0% more first-time investments, than exits
New positions opened: 25 | Existing positions closed: 25
83% less call options, than puts
Call options by funds: $2.65M | Put options by funds: $15.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
+$60.7M |
| 2 |
WCA
Waypoint Capital Advisors
Minneapolis,
Minnesota
|
+$30M |
| 3 |
Janus Henderson Group
London,
|
+$22M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$21M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$19.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
B
Braidwell
Stamford,
Connecticut
|
-$35.9M |
| 2 |
APM
Avidity Partners Management
Dallas,
Texas
|
-$16M |
| 3 |
DM
Deerfield Management
New York
|
-$12.9M |
| 4 |
FTM
First Turn Management
Del Mar,
California
|
-$12.5M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
-$9.84M |
APGE Hedge Fund Activity: Q3 2024 in Review
139 of the 6,978 institutional investors tracked by Wall St. Rank reported a position in Apogee Therapeutics (APGE) for Q3 2024, worth a combined $3.29B — up 55% from $2.13B a quarter earlier.
Fund positioning in APGE was balanced in Q3 2024: 25 funds opened new positions, 25 closed out, 48 added to existing stakes and 46 trimmed.
The largest buyer was Wellington Management Group, adding an estimated $60.7M. The largest seller was Braidwell, cutting an estimated $35.9M.
- 139 institutional investors held Apogee Therapeutics (APGE) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $3.29B of Apogee Therapeutics stock for Q3 2024, up 55% quarter-over-quarter.
- 25 funds opened new Apogee Therapeutics positions in Q3 2024 and 25 closed out, a net change of 0 holders.
- The largest Apogee Therapeutics buyer in Q3 2024 was Wellington Management Group, an estimated $60.7M added.
- The largest Apogee Therapeutics seller in Q3 2024 was Braidwell, an estimated $35.9M sold.
Based on aggregated 13F filings for Q3 2024.